Frederick J Wilson
Overview
Explore the profile of Frederick J Wilson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
471
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taylor Y, Wilson F, Kim M, Parker G
NMR Biomed
. 2024 Aug;
37(12):e5239.
PMID: 39183451
Sensitivity analysis enables the identification of influential parameters and the optimisation of model composition. Such methods have not previously been applied systematically to models describing hyperpolarised Xe gas exchange in...
2.
Longitudinal Lung Function Assessment of Patients Hospitalized With COVID-19 Using H and Xe Lung MRI
Saunders L, Collier G, Chan H, Hughes P, Smith L, Watson J, et al.
Chest
. 2023 Mar;
164(3):700-716.
PMID: 36965765
Background: Microvascular abnormalities and impaired gas transfer have been observed in patients with COVID-19. The progression of pulmonary changes in these patients remains unclear. Research Question: Do patients hospitalized with...
3.
4.
Chen D, Ballout S, Chen L, Cheriyan J, Choudhury G, Denis-Bacelar A, et al.
J Nucl Med
. 2020 Sep;
61(12):1701-1707.
PMID: 32948678
PET with F-FDG has been increasingly applied, predominantly in the research setting, to study drug effects and pulmonary biology and to monitor disease progression and treatment outcomes in lung diseases...
5.
Rangelov B, Young A, Jacob J, Cahn A, Lee S, Wilson F, et al.
Int J Chron Obstruct Pulmon Dis
. 2020 Aug;
15:1751-1787.
PMID: 32801677
Exacerbations of chronic obstructive pulmonary disease (COPD) are currently diagnosed based on changes in respiratory symptoms. Characterizing the imaging manifestation of exacerbations could be useful for objective diagnosis of exacerbations...
6.
Vass L, Fisk M, Lee S, Wilson F, Cheriyan J, Wilkinson I
Eur J Radiol
. 2020 Jul;
130:109182.
PMID: 32702614
Background: Respiratory diseases are one of the leading causes of death worldwide, yet effective treatment options remain limited. Although inflammation is thought to be a key driver in the pathogenesis...
7.
Maher T, Simpson J, Porter J, Wilson F, Chan R, Eames R, et al.
Respir Res
. 2020 Mar;
21(1):75.
PMID: 32216814
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease with poor prognosis and a significant unmet medical need. This study evaluated the safety, pharmacokinetics (PK) and target engagement...
8.
Onega M, Parker C, Coello C, Rizzo G, Keat N, Ramada-Magalhaes J, et al.
Eur J Nucl Med Mol Imaging
. 2020 Jan;
47(4):958-966.
PMID: 31897589
Purpose: Integrin αβ belongs to the RGD subset of the integrin family, and its expression levels are a prognostic and theranostic factor in some types of cancer and pulmonary fibrosis....
9.
Vass L, Lee S, Wilson F, Fisk M, Cheriyan J, Wilkinson I
EJNMMI Phys
. 2019 Dec;
6(1):26.
PMID: 31844995
Introduction: Compartmental modelling is an established method of quantifying F-FDG uptake; however, only recently has it been applied to evaluate pulmonary inflammation. Implementation of compartmental models remains challenging in the...
10.
Lukey P, Coello C, Gunn R, Parker C, Wilson F, Saleem A, et al.
Eur J Nucl Med Mol Imaging
. 2019 Dec;
47(4):967-979.
PMID: 31814068
Purpose: The RGD-integrin, αvβ6, plays a role in the pathogenesis of pulmonary fibrosis through activation of transforming growth factor beta (TGFβ). This study sought to quantify expression of αvβ6 in...